We acted for the shareholders of Medisource Ireland Limited on its sale to FTSE-listed DCC Group.
Medisource, operating in both Ireland and Northern Ireland, is a specialist in the procurement and sale of exempt medicinal products- pharmaceutical products which are imported with the authorisation of the relevant regulatory authority to meet the requirements of specific patients where no suitable licensed product is available.
DCC is an international sales, marketing, distribution and business support services group with revenues of £10.6 billion, employing over 10,500 people in 15 countries.
Gerry Halpenny, head of M&A at LK Shields, led the team on the sale with assistance from Corporate associates David Brangam and James Byrne. Catherine Walsh advised on the IP aspects of the transaction with Susan Battye and Jennifer O'Neill advising on employment matters.